Minor Salivary Gland Mesenchymal Stromal Cells Derived from Patients with Sjӧgren's Syndrome Deploy Intact Immune Plasticity

Sara S. McCoy,Jayeeta Giri,Rahul Das,Pradyut K. Paul,Andrea Pennati,Maxwell Parker,Yun Liang,Jacques Galipeau
DOI: https://doi.org/10.1016/j.jcyt.2020.09.008
IF: 6.196
2020-01-01
Cytotherapy
Abstract:Background aims: Mesenchymal stromal cells (MSCs) provide minor salivary glands (MSGs) with support and niche cells for epithelial glandular tissue. Little is known about resident MSG-derived MSCs (MSG-MSCs) in primary Sjo?gren's syndrome (PSS). The authors? objective is to define the immunobiology of endogenous PSS MSG-MSCs. Methods: Using culture-adapted MSG-MSCs isolated from consenting PSS subjects (n = 13), the authors performed in vitro interrogation of PSS MSG-MSC immunobiology and global gene expression compared with controls. To this end, the authors performed phenotypic and immune functional analysis of indoleamine 2,3dioxygenase (IDO), programmed death ligand 1 (PD-L1) and intercellular adhesion marker 1 (ICAM-1) before and after interferon g (IFNg) licensing as well as the effect of MSG-MSCs on T-cell proliferation. Considering the female predominance of PSS, the authors also addressed the influence of 17-b-estradiol on estrogen receptor a-positive-related MSC function. Results: The authors found that MSG-MSCs deployed normal immune regulatory functionality after IFNg stimulation, as demonstrated by increased protein-level expression of IDO, PD-L1 and ICAM-1. The authors also found that MSG-MSCs suppressed T-cell proliferation in a dose-dependent manner independent of 17b-estradiol exposure. Gene ontology and pathway analysis highlighted extracellular matrix deposition as a possible difference between PSS and control MSG-MSCs. MSG-MSCs demonstrated increased a-smooth muscle actin expression in PSS, indicating a partial myofibroblast-like adaptation. Conclusions: These findings establish similar immune regulatory function of MSG-MSCs in both PSS and control patients, precluding intrinsic MSC immune regulatory defects in PSS. PSS MSG-MSCs show a partial imprinted myofibroblast-like phenotype that may arise in the setting of chronic inflammation, providing a plausible etiology for PSS-related glandular fibrosis. 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?